These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21711313)

  • 41. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
    Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Behaviour of equine influenza virus in a naïve population: a practitioner's perspective.
    Major DA; Jones B
    Aust Vet J; 2011 Jul; 89 Suppl 1():13-4. PubMed ID: 21711271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-time RT-PCR for detection of equine influenza and evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8).
    Foord AJ; Selleck P; Colling A; Klippel J; Middleton D; Heine HG
    Vet Microbiol; 2009 May; 137(1-2):1-9. PubMed ID: 19153018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the diagnostic laboratories during the 2007 equine influenza outbreak in Australia.
    Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():29-32. PubMed ID: 21711280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus.
    Quinlivan M; Nelly M; Prendergast M; Breathnach C; Horohov D; Arkins S; Chiang YW; Chu HJ; Ng T; Cullinane A
    Vaccine; 2007 Oct; 25(41):7056-64. PubMed ID: 17825959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence of equine influenza virus in north-east and southern Mexico.
    Blitvich BJ; Ibarra-Juarez LA; Cortes-Guzman AJ; Root JJ; Franklin AB; Sullivan HJ; Fernandez-Salas I
    Vet Rec; 2010 May; 166(18):565-6. PubMed ID: 20435984
    [No Abstract]   [Full Text] [Related]  

  • 49. Attack risk on infected properties during the 2007 equine influenza outbreak in New South Wales, Australia.
    Dhand NK; Sergeant ES
    Aust Vet J; 2011 Jul; 89 Suppl 1():70-2. PubMed ID: 21711294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
    Adams AA; Sturgill TL; Breathnach CC; Chambers TM; Siger L; Minke JM; Horohov DW
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):128-40. PubMed ID: 21035197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.
    Bryant NA; Paillot R; Rash AS; Medcalf E; Montesso F; Ross J; Watson J; Jeggo M; Lewis NS; Newton JR; Elton DM
    Vet Res; 2010; 41(2):19. PubMed ID: 19863903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterisation of an H3N8 equine influenza virus in Australia, 2007.
    Watson J; Halpin K; Selleck P; Axell A; Bruce K; Hansson E; Hammond J; Daniels P; Jeggo M
    Aust Vet J; 2011 Jul; 89 Suppl 1():35-7. PubMed ID: 21711282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An outbreak of equine influenza virus in vaccinated horses in Italy is due to an H3N8 strain closely related to recent North American representatives of the Florida sub-lineage.
    Martella V; Elia G; Decaro N; Di Trani L; Lorusso E; Campolo M; Desario C; Parisi A; Cavaliere N; Buonavoglia C
    Vet Microbiol; 2007 Mar; 121(1-2):56-63. PubMed ID: 17197135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The August 2007 equine influenza response management framework.
    Webster WR
    Aust Vet J; 2011 Jul; 89 Suppl 1():92-7. PubMed ID: 21711301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-level coordination and strategy in the 2007 equine influenza outbreak response.
    Glanville RJ; Christie B
    Aust Vet J; 2011 Jul; 89 Suppl 1():97-100. PubMed ID: 21711302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innovative zoning to support equine influenza eradication from New South Wales, Australia.
    Scott-Orr H
    Aust Vet J; 2011 Jul; 89 Suppl 1():113-6. PubMed ID: 21711306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.